glp-1 depression Reassuring' findings suggest receptor agonists do not increase suicide risk GLP-1 Drug Improved Motivation in

Nauck MA, El-Ouaghlidi A, Gabrys B, Hcking K, Holst JJ, Deacon CF, et al

Among survey respondents, 76% provide GLP-1 drug coverage for diabetes, 27% provide coverage for weight loss, and 13% are considering covering for weight loss

GLP-1 medications like Ozempic (semaglutide GLP-1) are generally considered safe for long-term use when prescribed and monitored by a healthcare provider

Other delivery routes for GLP-1 RAs have also been investigated

Diabetes Complications 31 , 218222 (2017)

The study found increased risk in both patients with type 2 diabetes and patients using semaglutide for overweight or obesity, but the authors noted that the study was observational and could not prove that semaglutide directly caused NAION